AUD 0.8
(2.56%)
Year | Inventory | Inventory Growth |
---|---|---|
2024 | 439.91 Thousand AUD | -52.18% |
2023 | 919.92 Thousand AUD | 54.93% |
2022 | 593.75 Thousand AUD | 65.03% |
2021 | 359.78 Thousand AUD | 52.9% |
2020 | 235.3 Thousand AUD | 217.17% |
2019 | 74.19 Thousand AUD | 32.0% |
2018 | 56.2 Thousand AUD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q3 | 439.91 Thousand AUD | -31.54% |
2024 Q2 | 642.55 Thousand AUD | 0.0% |
2024 Q4 | 439.91 Thousand AUD | 0.0% |
2024 FY | 439.91 Thousand AUD | -52.18% |
2024 Q1 | 642.55 Thousand AUD | 8.22% |
2023 Q1 | 1.21 Million AUD | 104.07% |
2023 Q2 | 1.21 Million AUD | 0.0% |
2023 FY | 919.92 Thousand AUD | 54.93% |
2023 Q4 | 593.75 Thousand AUD | -35.46% |
2023 Q3 | 919.92 Thousand AUD | -24.08% |
2022 Q1 | 509.94 Thousand AUD | 41.74% |
2022 Q4 | 593.75 Thousand AUD | 0.0% |
2022 FY | 593.75 Thousand AUD | 65.03% |
2022 Q3 | 593.75 Thousand AUD | 16.44% |
2022 Q2 | 509.94 Thousand AUD | 0.0% |
2021 Q1 | 428.16 Thousand AUD | 81.96% |
2021 FY | 359.78 Thousand AUD | 52.9% |
2021 Q4 | 359.78 Thousand AUD | 0.0% |
2021 Q3 | 359.78 Thousand AUD | 47.59% |
2021 Q2 | 243.76 Thousand AUD | -43.07% |
2020 FY | 235.3 Thousand AUD | 217.17% |
2020 Q4 | 235.3 Thousand AUD | -21.98% |
2020 Q3 | 301.58 Thousand AUD | 0.0% |
2020 Q1 | - AUD | 0.0% |
2019 FY | 74.19 Thousand AUD | 32.0% |
2018 FY | 56.2 Thousand AUD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Althea Group Holdings Limited | 3.98 Million AUD | 88.955% |
Cann Group Limited | 10.18 Million AUD | 95.682% |
ECS Botanics Holdings Ltd | 12.98 Million AUD | 96.612% |
Ecofibre Limited | 2.63 Million AUD | 83.273% |
Elixinol Wellness Limited | 3.66 Million AUD | 87.994% |
Hygrovest Limited | - AUD | -Infinity% |
IDT Australia Limited | 1.68 Million AUD | 73.83% |
Invion Limited | -1.21 Million AUD | 136.344% |
Little Green Pharma Ltd | 8.9 Million AUD | 95.062% |
Medical Developments International Limited | 8.77 Million AUD | 94.984% |
Vitura Health Limited | 5.01 Million AUD | 91.22% |
Vita Life Sciences Limited | 11.15 Million AUD | 96.056% |